Talking to reporters here, Prof Dr Shiva Kumar Sarin, Former Chair, Medical Council of India, said as there was no cure for this type of cancer, USA had recently come out with an oral medicine, with 90 to 95 per cent efficacy, and the cost of which ranged from Rs 50 lakh to Rs 60 lakh.
The affected person has to take one tablet daily, costing USD 900 to 1,000 for three to six months.
Hepatitis C claims 300 times lives than HIV, he said quoting a recent survey that there were 1.5 crore persons affected with Hepatitis C, of which only a very few were diagnosed.
Dr V G Mohan Prasad, President, ISG, said that the society would make a representation to the government, through signature campaign on the need for affordable treatment and also the free screening on Hepatitis B and C virus, so that awareness can be created among the public for periodical blood check up.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
